Consideration of frailty versus limited life expectancy when deprescribing: A response to: ‘LESS CHRON: A tool for deprescribing in patients with multimorbidity’

Reeve, E

Consideration of frailty versus limited life expectancy when deprescribing: A response to: ‘LESS CHRON: A tool for deprescribing in patients with multimorbidity’

journal contribution

posted on 2021-04-01, 00:00 authored by E Reeve

Consideration of frailty versus limited life expectancy when deprescribing: A response to: ‘LESS CHRON: A tool for deprescribing in patients with multimorbidity’

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1002/jppr.1725

Language

English

Author URL

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000640298800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

C4 Letter or note

Journal

Journal of Pharmacy Practice and Research

Volume

51

Pagination

185-186

ISSN

1445-937X

eISSN

2055-2335

Issue

2

Publisher

WILEY

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy

Consideration of frailty versus limited life expectancy when deprescribing: A response to: ‘LESS CHRON: A tool for deprescribing in patients with multimorbidity’

History

Related Materials

Language

Author URL

Publication classification

Journal

Volume

Pagination

ISSN

eISSN

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports